Connect with us
Abivax shares surged nearly 36% after positive updated trial results for its ulcerative colitis drug obefazimod reassured investors following earlier safety concerns. New data showed strong...
Eli Lilly stock hit a record high, surpassing $1 trillion market value after strong product demand. Shares surged over 7%, entering price discovery with bullish RSI...
Gilead’s upcoming development plan for Assembly Biosciences’ HSV drugs could reshape the herpes market. ABI-5366 and ABI-1179 have shown strong antiviral results and may form a...
Galicia has approved its Biotechnology Strategy 2026–2030, mobilizing €805 million to boost competitiveness. The plan prioritizes health, agri-food, and advanced technologies, including the 1HealthAI hub. It...
Biotechnology company Graph Therapeutics raised 5 million dollars in a funding round led by Daphni, with support from existing investors. Including grants from Austrian agencies, total...
Gene therapies are transforming rare disease treatment, enabling normal lives for some patients. However, only about 6% of 7,000 rare diseases have treatments. Advances show curative...
Bavaria’s biotech sector grew in 2025, with companies rising 1.5% to 548 and funding exceeding €930 million. Startups surged, with 26 new firms. Employment reached 59,000....
AseBio presented its 2025 report on the Biotech Act, highlighting opportunities for Spanish biotechnology while urging greater ambition, funding, and implementation. Spain’s biotech sector shows strong...
New biomarkers and targeted therapies are reshaping the management of kidney damage in autoimmune diseases like lupus and vasculitis. Experts at a Spanish medical meeting highlighted...
EFPIA supports the EU Biotechnology Law and a 12-month SPC extension but warns the current proposal is too limited. A broader scope could attract up to...
 |
|
 |  |
 |
|